(2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide

C135H183F6N23O18 — CID 160581602

IUPAC(2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide
SMILESCC(C)(COc1cnccc1C(F)(F)F)NC(=O)C1CNCCOC1.CC(C)(COc1cnccc1C(F)(F)F)NC(=O)[C@@H]1CNCCO1.CC(C)(NC(=O)C1CNCCOC1)c1cccc2ccccc12.CC(C)(NC(=O)C1CNCCOC1)c1cccc2ccccc12.CC(C)(NC(=O)[C@@H]1CNCCO1)C1CCCCC1.CC(C)(NC(=O)[C@H]1CNCCO1)c1ccnc2ccccc12.Cc1cc2cccnc2c(C(C)(C)NC(=O)C2CNCCOC2)n1.Cc1cccn2c(C3(NC(=O)C4CNCCOC4)CC3)ncc12
InChIInChI=1S/2C19H24N2O2.C18H24N4O2.C17H22N4O2.C17H21N3O2.C16H22F3N3O3.C15H20F3N3O3.C14H26N2O2/c2*1-19(2,21-18(22)15-12-20-10-11-23-13-15)17-9-5-7-14-6-3-4-8-16(14)17;1-12-9-13-5-4-6-20-15(13)16(21-12)18(2,3)22-17(23)14-10-19-7-8-24-11-14;1-12-3-2-7-21-14(12)10-19-16(21)17(4-5-17)20-15(22)13-9-18-6-8-23-11-13;1-17(2,20-16(21)15-11-18-9-10-22-15)13-7-8-19-14-6-4-3-5-12(13)14;1-15(2,22-14(23)11-7-21-5-6-24-9-11)10-25-13-8-20-4-3-12(13)16(17,18)19;1-14(2,21-13(22)12-8-20-5-6-23-12)9-24-11-7-19-4-3-10(11)15(16,17)18;1-14(2,11-6-4-3-5-7-11)16-13(17)12-10-15-8-9-18-12/h2*3-9,15,20H,10-13H2,1-2H3,(H,21,22);4-6,9,14,19H,7-8,10-11H2,1-3H3,(H,22,23);2-3,7,10,13,18H,4-6,8-9,11H2,1H3,(H,20,22);3-8,15,18H,9-11H2,1-2H3,(H,20,21);3-4,8,11,21H,5-7,9-10H2,1-2H3,(H,22,23);3-4,7,12,20H,5-6,8-9H2,1-2H3,(H,21,22);11-12,15H,3-10H2,1-2H3,(H,16,17)/t;;;;15-;;2*12-/m....1.00/s1
InChIKeyRBVYJCFJABFYLE-JSRRHJLTSA-N
MW2530.08 g/mol
LogP13.36
Rot. Bonds28

About (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide

(2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide (PubChem CID 160581602) has the molecular formula C135H183F6N23O18 and a molecular weight of 2530.08 g/mol. Its IUPAC name is (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide.

Molecular Properties

Compound Name(2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide
PubChem CID160581602
Molecular FormulaC135H183F6N23O18
Molecular Weight2530.08 g/mol
Exact Mass2528.40
IUPAC Name(2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide
SMILESCC(C)(COc1cnccc1C(F)(F)F)NC(=O)C1CNCCOC1.CC(C)(COc1cnccc1C(F)(F)F)NC(=O)[C@@H]1CNCCO1.CC(C)(NC(=O)C1CNCCOC1)c1cccc2ccccc12.CC(C)(NC(=O)C1CNCCOC1)c1cccc2ccccc12.CC(C)(NC(=O)[C@@H]1CNCCO1)C1CCCCC1.CC(C)(NC(=O)[C@H]1CNCCO1)c1ccnc2ccccc12.Cc1cc2cccnc2c(C(C)(C)NC(=O)C2CNCCOC2)n1.Cc1cccn2c(C3(NC(=O)C4CNCCOC4)CC3)ncc12
InChIInChI=1S/2C19H24N2O2.C18H24N4O2.C17H22N4O2.C17H21N3O2.C16H22F3N3O3.C15H20F3N3O3.C14H26N2O2/c2*1-19(2,21-18(22)15-12-20-10-11-23-13-15)17-9-5-7-14-6-3-4-8-16(14)17;1-12-9-13-5-4-6-20-15(13)16(21-12)18(2,3)22-17(23)14-10-19-7-8-24-11-14;1-12-3-2-7-21-14(12)10-19-16(21)17(4-5-17)20-15(22)13-9-18-6-8-23-11-13;1-17(2,20-16(21)15-11-18-9-10-22-15)13-7-8-19-14-6-4-3-5-12(13)14;1-15(2,22-14(23)11-7-21-5-6-24-9-11)10-25-13-8-20-4-3-12(13)16(17,18)19;1-14(2,21-13(22)12-8-20-5-6-23-12)9-24-11-7-19-4-3-10(11)15(16,17)18;1-14(2,11-6-4-3-5-7-11)16-13(17)12-10-15-8-9-18-12/h2*3-9,15,20H,10-13H2,1-2H3,(H,21,22);4-6,9,14,19H,7-8,10-11H2,1-3H3,(H,22,23);2-3,7,10,13,18H,4-6,8-9,11H2,1H3,(H,20,22);3-8,15,18H,9-11H2,1-2H3,(H,20,21);3-4,8,11,21H,5-7,9-10H2,1-2H3,(H,22,23);3-4,7,12,20H,5-6,8-9H2,1-2H3,(H,21,22);11-12,15H,3-10H2,1-2H3,(H,16,17)/t;;;;15-;;2*12-/m....1.00/s1
InChIKeyRBVYJCFJABFYLE-JSRRHJLTSA-N
XLogP13.36
TPSA503.09 Ų
H-Bond Donors16
H-Bond Acceptors33
Rotatable Bonds28
Heavy Atoms182
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002530.08
LogP ≤ 513.36
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1033

Analyze (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]oxepane-3-carboxamide;N-[(1S)-1-naphthalen-1-ylethyl]-1,4-oxazepane-6-carboxamide;(2S)-N-(2-naphthalen-1-ylpropan-2-yl)oxane-2-carboxamide;N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide;(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide
CID 161234473
N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[2-(8-fluoroquinazolin-4-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[2-[8-fluoro-1-(trifluoromethyl)imidazo[1,5-a]pyridin-3-yl]propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;3-methyl-3-(2-methylquinazolin-4-yl)-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one
CID 161426549
N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,2-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-7-carboxamide;3-methyl-3-(8-methylindolizin-3-yl)-1-(1,4-oxazepan-6-yl)butan-1-one
CID 157996542
N-[2-(1-cyclopropyl-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(2,8-dimethylquinazolin-4-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-fluoroimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[2-(8-methoxyimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-1,4-oxazepane-6-carboxamide;(2S)-N-[3-(8-methylimidazo[1,5-a]pyridin-3-yl)oxolan-3-yl]morpholine-2-carboxamide;N-[1-(8-methylindolizin-3-yl)ethyl]-1,4-oxazepane-6-carboxamide
CID 162248853

Frequently Asked Questions

What is the IUPAC name of (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide?
The IUPAC name of (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide (CID 160581602) is (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide.
What is the SMILES notation for (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide?
The canonical SMILES for (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide is CC(C)(COc1cnccc1C(F)(F)F)NC(=O)C1CNCCOC1.CC(C)(COc1cnccc1C(F)(F)F)NC(=O)[C@@H]1CNCCO1.CC(C)(NC(=O)C1CNCCOC1)c1cccc2ccccc12.CC(C)(NC(=O)C1CNCCOC1)c1cccc2ccccc12.CC(C)(NC(=O)[C@@H]1CNCCO1)C1CCCCC1.CC(C)(NC(=O)[C@H]1CNCCO1)c1ccnc2ccccc12.Cc1cc2cccnc2c(C(C)(C)NC(=O)C2CNCCOC2)n1.Cc1cccn2c(C3(NC(=O)C4CNCCOC4)CC3)ncc12.
What is the InChIKey of (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide?
The InChIKey is RBVYJCFJABFYLE-JSRRHJLTSA-N. The full InChI is InChI=1S/2C19H24N2O2.C18H24N4O2.C17H22N4O2.C17H21N3O2.C16H22F3N3O3.C15H20F3N3O3.C14H26N2O2/c2*1-19(2,21-18(22)15-12-20-10-11-23-13-15)17-9-5-7-14-6-3-4-8-16(14)17;1-12-9-13-5-4-6-20-15(13)16(21-12)18(2,3)22-17(23)14-10-19-7-8-24-11-14;1-12-3-2-7-21-14(12)10-19-16(21)17(4-5-17)20-15(22)13-9-18-6-8-23-11-13;1-17(2,20-16(21)15-11-18-9-10-22-15)13-7-8-19-14-6-4-3-5-12(13)14;1-15(2,22-14(23)11-7-21-5-6-24-9-11)10-25-13-8-20-4-3-12(13)16(17,18)19;1-14(2,21-13(22)12-8-20-5-6-23-12)9-24-11-7-19-4-3-10(11)15(16,17)18;1-14(2,11-6-4-3-5-7-11)16-13(17)12-10-15-8-9-18-12/h2*3-9,15,20H,10-13H2,1-2H3,(H,21,22);4-6,9,14,19H,7-8,10-11H2,1-3H3,(H,22,23);2-3,7,10,13,18H,4-6,8-9,11H2,1H3,(H,20,22);3-8,15,18H,9-11H2,1-2H3,(H,20,21);3-4,8,11,21H,5-7,9-10H2,1-2H3,(H,22,23);3-4,7,12,20H,5-6,8-9H2,1-2H3,(H,21,22);11-12,15H,3-10H2,1-2H3,(H,16,17)/t;;;;15-;;2*12-/m....1.00/s1.
What are the key properties of (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide?
(2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide has a molecular weight of 2530.08 g/mol, XLogP of 13.36, 28 rotatable bonds, 16 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-(2-cyclohexylpropan-2-yl)morpholine-2-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-1,4-oxazepane-6-carboxamide;N-[2-(6-methyl-1,7-naphthyridin-8-yl)propan-2-yl]-1,4-oxazepane-6-carboxamide;(2S)-N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]morpholine-2-carboxamide;N-[2-methyl-1-[[4-(trifluoromethyl)-3-pyridinyl]oxy]propan-2-yl]-1,4-oxazepane-6-carboxamide;bis(N-(2-naphthalen-1-ylpropan-2-yl)-1,4-oxazepane-6-carboxamide);(2R)-N-(2-quinolin-4-ylpropan-2-yl)morpholine-2-carboxamide is sourced from PubChem (CID 160581602), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).